PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia
NCT00362544
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
Ambisome
Sponsor
Gilead Sciences